Article
Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
Biomolecules - 15 Feb 2021
Wei Jianshe, Takamatsu Yoshiki, Wada Ryoko, Fujita Masayo, Ho Gilbert, Masliah Eliezer, Hashimoto Makoto
Abstract excerpt
Gaucher disease (GD), the most common lysosomal storage disorder (LSD), is caused by autosomal recessive mutations of the glucocerebrosidase gene, GBA1. In the majority of cases, GD has a non-neuropathic chronic form with adult onset (GD1), while other cases are more acute and severer neuropathic forms with early onset (GD2/3). Currently, no radical therapies are established for GD2/3. Notably, GD1, but not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
